Literature DB >> 20502052

Adenovirus-mediated decorin gene transfection has therapeutic effects in a streptozocin-induced diabetic rat model.

Zhe Zhang1, Fang Wu, FenPing Zheng, Hong Li.   

Abstract

BACKGROUND/AIMS: Transforming growth factor beta(1) (TGF-beta(1)) is a key mediator in diabeticnephropathy (DN). Decorin, a natural inhibitor of TGF-beta(1), may have healing properties. We investigated whether overexpression of decorin in the kidneys of streptozocin (STZ)-induced diabetic rats improved pathogenic and clinical changes of DN.
METHODS: Forty-eight Sprague-Dawley rats were evenly divided into 4 groups: STZ-induced diabetic rats (diabetic-control), decorin adenovirus vector (Ad)-treated STZ rats (Ad-decorin), and Ad-lacZ-treated STZ rats (Ad-lacZ), and vehicle control (PBS-control). At 10, 12, and 16 weeks after STZ treatment, we measured urinary albumin excretion (UAE), and immunolabeled type IV collagen in histological samples of rat kidney. We also measured kidney decorin and TGF-beta(1) levels by reverse transcription polymerase chain reaction and Western blot. Phosphorylated Smad2,3 (p-Smad2,3) was also measured by Western blot.
RESULTS: Decorin gene transfection mediated by a recombinant adenovirus has antirenal fibrosis and anti-albuminuria effects in STZ-induced diabetic rats. TGF-beta(1) mRNA and protein expression in diabetic kidney were reduced 2 weeks after Ad-decorin injection.
CONCLUSION: The renal protective effect of decorin in diabetic rats is at least partly due to the downregulation of the TGF-beta(1)/Smad signaling pathway. Ad-decorin shows potential as a therapeutic for human DN. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502052     DOI: 10.1159/000314669

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  9 in total

1.  Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.

Authors:  Patricia G Wilson; Joel C Thompson; Meghan H Yoder; Richard Charnigo; Lisa R Tannock
Journal:  J Lipid Res       Date:  2017-09-14       Impact factor: 5.922

2.  Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice.

Authors:  Monica G Ferrini; Joanne Moon; Steve Rivera; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  BJU Int       Date:  2011-08-18       Impact factor: 5.588

3.  Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.

Authors:  Rajiv R Mohan; Ashish Tandon; Ajay Sharma; John W Cowden; Jonathan C K Tovey
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

4.  Effect of benazepril on the transdifferentiation of renal tubular epithelial cells from diabetic rats.

Authors:  Tao Peng; Jie Wang; Junhui Zhen; Zhao Hu; Xiangdong Yang
Journal:  Biomed Rep       Date:  2014-05-15

Review 5.  Diabetic nephropathy - complications and treatment.

Authors:  Andy Kh Lim
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-15

Review 6.  Nano-sized carriers in gene therapy for renal fibrosis in vivo.

Authors:  Haruhisa Miyazawa; Keiji Hirai; Susumu Ookawara; Kenichi Ishibashi; Yoshiyuki Morishita
Journal:  Nano Rev Exp       Date:  2017-06-13

7.  Heightened Crescentic Glomerulonephritis in Immune Challenged 129sv Mice Is TGF-β/Smad3 Dependent.

Authors:  Yong Du; Chun Xie; Sneha Ravikumar; Jacob Orme; Li Li; Xin J Zhou; Chandra Mohan
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

8.  Recombinant fibromodulin has therapeutic effects on diabetic nephropathy by down-regulating transforming growth factor-β1 in streptozotocin-induced diabetic rat model.

Authors:  Maryam Foroutan Jazi; Alireza Biglari; Saeideh Mazloomzadeh; Paul Kingston; Ali Ramazani; Javad Tavkoli Bazzaz; Mehdi Eskandari
Journal:  Iran J Basic Med Sci       Date:  2016-03       Impact factor: 2.699

9.  Decorin Concentrations in Aqueous Humor of Patients with Diabetic Retinopathy.

Authors:  Shermaine W Y Low; Tanuja Vaidya; Santosh G K Gadde; Thirumalesh B Mochi; Devesh Kumar; Iris S Kassem; Deborah M Costakos; Baseer Ahmad; Swaminathan Sethu; Arkasubhra Ghosh; Shyam S Chaurasia
Journal:  Life (Basel)       Date:  2021-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.